Reply to: “Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ”

Handrean Soran; Safwaan Adam; Paul N. Durrington

doi:10.1016/j.atherosclerosis.2018.11.033

Reply to: “Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ”

Handrean Soran^*, Safwaan Adam, Paul N. Durrington

^*Corresponding author for this work

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	214-215
Number of pages	2
Journal	Atherosclerosis
Volume	281
DOIs	https://doi.org/10.1016/j.atherosclerosis.2018.11.033
Publication status	Published - Feb 2019

Keywords

Cardiovascular disease
Clinical guidelines
LDL-C
Number needed to treat

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.atherosclerosis.2018.11.033

Cite this

@article{d71a8659fdc24c99929e804c272876e3,

title = "Reply to: “Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ”",

keywords = "Cardiovascular disease, Clinical guidelines, LDL-C, Number needed to treat",

author = "Handrean Soran and Safwaan Adam and Durrington, {Paul N.}",

year = "2019",

month = feb,

doi = "10.1016/j.atherosclerosis.2018.11.033",

language = "English",

volume = "281",

pages = "214--215",

journal = "Atherosclerosis",

issn = "0021-9150",

publisher = "Elsevier BV",

}

Reply to: “Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ”. / Soran, Handrean; Adam, Safwaan; Durrington, Paul N.
In: Atherosclerosis, Vol. 281, 02.2019, p. 214-215.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Reply to

T2 - “Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ”

AU - Soran, Handrean

AU - Adam, Safwaan

AU - Durrington, Paul N.

PY - 2019/2

Y1 - 2019/2

KW - Cardiovascular disease

KW - Clinical guidelines

KW - LDL-C

KW - Number needed to treat

UR - http://www.scopus.com/inward/record.url?scp=85062066575&partnerID=8YFLogxK

U2 - 10.1016/j.atherosclerosis.2018.11.033

DO - 10.1016/j.atherosclerosis.2018.11.033

M3 - Letter

C2 - 30528192

AN - SCOPUS:85062066575

SN - 0021-9150

VL - 281

SP - 214

EP - 215

JO - Atherosclerosis

JF - Atherosclerosis

ER -

Reply to: “Comments on 'Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk' ”

Keywords

UN SDGs

Access to Document

Other files and links

Cite this